Business Model Breakdown
How Laser Photonics Corp Makes Money
LASE
Market Cap
$36M
Profit Margin
-209.2%
The Short Version
Laser Photonics Corp designs, manufactures, and sells industrial laser systems primarily for cleaning, surface preparation, and cutting applications in industrial and defense sectors. They generate revenue by selling these specialized laser machines directly to customers, who use them for tasks like removing rust, paint, and contaminants, or for precision manufacturing. Their subsidiary, CMS Laser, focuses on similar applications, serving customers like Johnson & Johnson.
Where the Revenue Comes From
Sales of industrial laser cleaning and cutting systems (primary revenue source, specific % not provided).
Sales of defense-related laser applications (contribution not specified).
Who buys: Industrial manufacturers (e.g., automotive, aerospace, medical device as suggested by J&J order), defense contractors, government entities.
Why It Works (Competitive Advantages)
- ✔Proprietary laser technology (implied by specialized industrial/defense applications).
- ✔Niche expertise in specific laser cleaning and processing systems.
- ✔Established customer relationships (e.g., Johnson & Johnson order).
Economic Moat: None (Intangible Assets/IP (if their laser technology is truly proprietary and protected).)
What Our Analysis Says
DVR Score as of June 3, 2026
Laser Photonics Corp presents an extremely high-risk, speculative investment due to its current financial and regulatory challenges. While operating in the growing industrial and defense laser market, evidenced by a recent $250,000 order from Johnson & Johnson, the company is severely hampered by a Nasdaq deficiency notice issued on May 21, 2026, for a delayed Q1 2026 Form 10-Q filing. This raises significant concerns about transparency, financial health, and potential delisting. The company reported negative EPS (-$0.12) for its most recent Q2 2025 results, and institutional ownership is minimal at 1.90%. Achieving 10x growth requires addressing these fundamental issues, regaining compliance, and demonstrating consistent profitability and strong organic growth, none of which are currently evident. The severe regulatory risk heavily penalizes the overall score.